Zepbound® (tirzepatide) is an FDA approved prescription medication indicated for chronic weight management in adults with obesity and in adults who are overweight with at least one weight related comorbid condition. It acts by mimicking the endogenous gut hormone (GLP-1) involved in appetite regulation, promoting satiety, reducing caloric intake, and improving glycemic control. When used alongside a reduced calorie diet and increased physical activity, Zepbound® has been shown to support average total body weight loss of up to approximately 20 percent.
During your clinical consultation at Altius, we take the time to understand your health history, weight management goals, and lifestyle. Our licensed medical providers will assess whether Zepbound® is an appropriate option for you, explain how it works, and review the expected benefits and potential risks. If prescribed, treatment typically starts at a low dose to minimize side effects, with gradual dose increases over several weeks as tolerated.
Zepbound® is administered as a once weekly subcutaneous injection using a small, simple needle, typically in the abdomen or thigh. Our team will provide clear instruction to ensure you feel confident administering the medication. All treatments at Altius require a consultation with a licensed healthcare provider, and prescriptions are issued solely at the provider’s clinical discretion following a comprehensive review of your medical history and overall health profile.
Common side effects of Zepbound® may include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, injection site reactions, drowsiness, allergic reactions, gas, hair thinning or loss, and heartburn. Zepbound® should not be used in individuals with a personal or family history of medullary thyroid carcinoma or in those with Multiple Endocrine Neoplasia syndrome type 2. For further safety information, please visit https://uspl.lilly.com/zepbound/zepbound.html.
**The information provided on this website is for informational purposes only and is not intended to replace professional medical advice. Always consult a qualified healthcare provider regarding any questions about your health, diagnosis, or treatment.
**Medication and FDA Information: Our clinic prescribes medications based on your individual health profile and clinical appropriateness. Wegovy® (semaglutide) and Zepbound® (tirzepatide) are FDA approved for chronic weight management. Other medications, including Ozempic® (semaglutide) and Mounjaro® (tirzepatide), are FDA approved for the treatment of type 2 diabetes and may be prescribed off label for weight loss at the provider’s clinical discretion.
**Compounded Medications: Our clinic may also offer compounded medications, such as Sermorelin or compounded GLP-1 therapies, prepared by a state licensed sterile compounding pharmacy. Compounded medications are not FDA approved, and the FDA does not review or verify their safety, efficacy, or manufacturing quality.
**Trademarks and Affiliation: Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Altius Performance Medicine is not affiliated with, endorsed by, or an official partner of Novo Nordisk A S or Eli Lilly and Company.
**FSA and HSA eligibility and coverage vary by plan and administrator.
Testimonials
- Dillon C.
Meet Our Providers
